Extension of Research- and Co-operation Agreement between PhotoCure ASA and The Norwegian Radium Hospital

PhotoCure ASA (PC), the Norwegian Radium Hospital (NRH), and NRH Research Foundation (RF) have extended the research-and co-operation agreement through the year 2002. The agreement covers research and development in connection with commercialization of pharmaceutical products within photodynamic cancer diagnostics and treatment, cancer vaccines and gene therapy.

PC has through this agreement secured exclusive, worldwide, rights to use and exploit NRH/RF technology and know-how within photodynamic therapy (PDT). PC also has an option to acquire, fully or in part new technology and know-how or improvements of existing technology within PDT.

RF/NRH and PC shall, according to this agreement also keep each other informed about developments within the field which could be of importance for the commercialization of PC’s existing or new products for PDT.

PC pays a compensation to RF/NRH to be used for clinical and pre-clinical research within the field of photodynamic therapy for the rights that it has acquired under this agreement.